Australia's most trusted
source of pharma news
Friday, 7 August 2026
Friday, 7 August 2026
Subscribe
Login
Great workplace, six years running
An impressive 95 per cent of this pharma team have ranked their company as a 'great place to work' and it's not the first time with the organisation earning its sixth Great Place to Work nod.
Company announces fresh layoffs
A cost-saving program that started in 2023 has been extended again bringing more job cuts plus the other popular stories this week
TODAY Your Week in 5 Minutes
Doctors turn up heat on pharma
Pharma is not alone in feeling frustration over timely access to medicines, doctors are feeling the pain too and want industry to fix it
TODAY
Pharma flags more job cuts
An ongoing 'cost base realignment' has been extended with more global redundancies but the impact on the local team is unknown
6 August
Ex-J&J boss lands 5th Country Leader job
Seasoned industry executive takes top job in expanding business with a growing portfolio of essential medicines
6 August
New rival to crash CAR-T market
A new CAR-T submitted to the TGA and MSAC looks set to take on Novartis' Kymriah and Gilead's Yescarta
6 August
After 8 OS deaths TGA reviews drug
With overseas regulators well down the path to removing this treatment from their market, the TGA has announced it's undertaking a review
4 August
Latest Jobs
Customer Service Representative / Order ProcessingTerritory ManagerCustomer Service CoordinatorQuality Assurance AssociateWarehouse AssistantSenior Recruitment ConsultantTerritory ManagerTerritory Manager40 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (22)
- Customer Service Representative / Order Processing - Macquarie Park
- Territory Manager - Melbourne
- Customer Service Coordinator - Frenchs Forest
- Territory Manager - Sydney
- Territory Manager - Brisbane
- Territory Manager - Perth
- Medical Sales Representative - Brisbane
- Inside Sales Specialist - Melbourne
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Territory Manager - Auckland
- Territory Manager - Capital Equipment - Auckland
- Account Manager - Sydney
- Customer Service Representative - Lane Cove
- Customer Service Manager - Frenchs Forest
- Territory Manager - Devices - Gold Coast
- Head of Sales - Community Care - Sydney
- Business Development Manager - Acute Care - Melbourne
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Sydney
- Territory Manager - Newcastle
- Medical Sales Representative - Sydney
Access & Reimbursement (2)
- Associate Director, Market Access & HEOR, Canada - Toronto
- Senior Manager, Market Access ANZ - Melbourne
Clinical & Medical, R&D (9)
- Medical Sales Representative - Brisbane
- Clinical Research Coordinator - Botany
- Clinical Compliance Specialist - 0.6FTE+ - Melbourne / Sydney (remote with some on-site client work)
- Clinical Research Investigator - Allambie Heights
- Clinical Research Associate - Sydney
- Medical Science Liaison - Sydney
- Clinical Trial Study Start Up Specialist - Melbourne
- Medical Sales Representative - Sydney
- Clinical Research Associate II - Melbourne
Regulatory, Pharmacovigilance & QA (4)
- Quality Assurance Associate - Tullamarine
- Senior Technical & Regulatory Associate - Sydney
- Quality Associate - Sydney
- Senior Quality Engineer - Tullamarine
Devices (1)
Executive Roles (2)
- Associate Director, Market Access & HEOR, Canada - Toronto
- Senior Manager, Market Access ANZ - Melbourne
Other (12)
- Warehouse Assistant - Macquarie Park
- Senior Recruitment Consultant - Sydney CBD
- HSE & Facilities Manager - Frenchs Forest
- Senior Project Manager - Operations - Sydney
- Procurement Specialist - North Sydney
- Warehouse Assistant & Forklift Driver - Lane Cove West
- Supply Chain Coordinator - Sydney
- Head of Unlicensed Medicines - Sydney
- Warehouse Assistant - North Ryde
- Senior Payroll Specialist - Macquarie Park
- Commercial Specialist - Brisbane
- Distribution Clerk - Warehousing - Jacana
$170M franchise safe for a year
An injunction has prevented four drugs from facing first generic price cuts for at least another 12 months but the legal battle is far from over
TODAY
More to the story for patients
Pharma innovation has greatly extended the lifespan of people living with this disease, but now there are new challenges
TODAY
Aussie peanut drug on fast track
Melbourne based company backed in part by the Novartis Future fund wins an FDA fast track for its peanut allergy immunotherapy
6 August
Diabetes drug restrictions gone
A big win for three companies with NZ's Pharmac extending access to their diabetes treatments to a further 30,000 Kiwis
6 August
Who's keeping eyes on rival Reps?
New service reveals which HCPs have interacted with competitor sales reps and it could be heading Down Under
5 August
Pharma exec up for Patient Choice gong
77 finalists across 15 categories selected by the patients, families, colleagues and communities who have experienced their work first-hand
5 August
The pharmacy of unavailable drugs
A powerful experience of being unable to access much-needed medicine is building public pressure for more drug funding
5 August
Who's moved to global HQ?
Two leaders promoted to new roles, one landing a regional gig while the other has moved to international headquarters
5 August
Backlash over PBAC monitoring
Pharma's unease with the PBAC's monitoring system of updated OS results of cancer drugs has been exposed in new documents
5 August
$300M blockbuster falls off patent
First time generic competition for half a dozen drugs, including a top seller, ushers in painful statutory price reductions
4 August
Who's jumped ship to be first CMO?
A pharma filling its first Chief Medical Officer position has landed an industry veteran with extensive experience in launching new indications
Deal paves way for global rollout
Exclusive license agreement for new cancer drug worth up to $601.9 million and covering 66 countries, including Australia
4 August
Med affairs, the time is now
A call to action has sounded: This cross-disciplinary team is urging a fundamental change to how Medical Affairs reach HCPs
4 August
Eight pharmas win PBS listings
A wave of PBS listings for August with more than half covering new medicines including the first new treatment option in 20 years
3 August